404 related articles for article (PubMed ID: 37508557)
41. Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
Joyce SA; Gahan CG
Dig Dis; 2017; 35(3):169-177. PubMed ID: 28249284
[TBL] [Abstract][Full Text] [Related]
42. Bile Acid Signaling in Inflammatory Bowel Diseases.
Fiorucci S; Carino A; Baldoni M; Santucci L; Costanzi E; Graziosi L; Distrutti E; Biagioli M
Dig Dis Sci; 2021 Mar; 66(3):674-693. PubMed ID: 33289902
[TBL] [Abstract][Full Text] [Related]
43. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis.
Grüner N; Mattner J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573273
[TBL] [Abstract][Full Text] [Related]
44. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation.
Thibaut MM; Bindels LB
Trends Mol Med; 2022 Mar; 28(3):223-236. PubMed ID: 35074252
[TBL] [Abstract][Full Text] [Related]
45. Bile acid metabolism and signaling, the microbiota, and metabolic disease.
Cai J; Rimal B; Jiang C; Chiang JYL; Patterson AD
Pharmacol Ther; 2022 Sep; 237():108238. PubMed ID: 35792223
[TBL] [Abstract][Full Text] [Related]
46. Diversification of host bile acids by members of the gut microbiota.
Winston JA; Theriot CM
Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
[TBL] [Abstract][Full Text] [Related]
47. Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms.
Yu Z; Li D; Sun H
Biomed Pharmacother; 2023 May; 161():114409. PubMed ID: 36822021
[TBL] [Abstract][Full Text] [Related]
48. Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction.
Yu S; Sun Y; Shao X; Zhou Y; Yu Y; Kuai X; Zhou C
J Microbiol Biotechnol; 2022 Jul; 32(7):825-834. PubMed ID: 35791076
[TBL] [Abstract][Full Text] [Related]
49. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
50. The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms.
Chen J; Sali A; Vitetta L
Future Microbiol; 2020 May; 15():541-555. PubMed ID: 32478580
[TBL] [Abstract][Full Text] [Related]
51. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
[TBL] [Abstract][Full Text] [Related]
52. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
53. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
54. The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice.
Chu H; Jiang L; Gao B; Gautam N; Alamoudi JA; Lang S; Wang Y; Duan Y; Alnouti Y; Cable EE; Schnabl B
Transl Res; 2021 Jan; 227():1-14. PubMed ID: 32553670
[TBL] [Abstract][Full Text] [Related]
55. How Microbial Food Fermentation Supports a Tolerant Gut.
Poppe J; van Baarle L; Matteoli G; Verbeke K
Mol Nutr Food Res; 2021 Mar; 65(5):e2000036. PubMed ID: 32996681
[TBL] [Abstract][Full Text] [Related]
56. Gut microbiome as a therapeutic target for liver diseases.
Singh TP; Kadyan S; Devi H; Park G; Nagpal R
Life Sci; 2023 Jun; 322():121685. PubMed ID: 37044173
[TBL] [Abstract][Full Text] [Related]
57. Roux-en-Y Gastric-Bypass and sleeve gastrectomy induces specific shifts of the gut microbiota without altering the metabolism of bile acids in the intestinal lumen.
Duboc H; Nguyen CC; Cavin JB; Ribeiro-Parenti L; Jarry AC; Rainteau D; Humbert L; Coffin B; Le Gall M; Bado A; Sokol H
Int J Obes (Lond); 2019 Feb; 43(2):428-431. PubMed ID: 29453461
[TBL] [Abstract][Full Text] [Related]
58. Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa.
Distrutti E; Santucci L; Cipriani S; Renga B; Schiaroli E; Ricci P; Donini A; Fiorucci S
J Gastroenterol; 2015 Jul; 50(7):707-19. PubMed ID: 25708288
[TBL] [Abstract][Full Text] [Related]
59. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
Nie YF; Hu J; Yan XH
J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
[TBL] [Abstract][Full Text] [Related]
60. Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation.
Wang Q; Hao C; Yao W; Zhu D; Lu H; Li L; Ma B; Sun B; Xue D; Zhang W
BMC Gastroenterol; 2020 Mar; 20(1):59. PubMed ID: 32143645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
